You are here

  • Home
  • Archive
  • Volume 105, Issue 9
  • P60 Efficacy of switching to infliximab biosimilar (Remsima®) in paediatric inflammatory bowel disease (PIBD): a 2-Year retrospective evaluation

Article metrics

Article menu

Download PDFPDF

Abstracts from the Neonatal and Paediatric Pharmacists Conference November 2019
Sutton Coldfield, UK
P60 Efficacy of switching to infliximab biosimilar (Remsima®) in paediatric inflammatory bowel disease (PIBD): a 2-Year retrospective evaluation
Free

 

Online download statistics by month:

Online download statistics by month: August 2020 to November 2024

AbstractFullPdf
Aug 2020185022
Sep 2020136013
Oct 20206605
Nov 20201103
Dec 20203606
Jan 202118010
Feb 20211707
Mar 20211404
Apr 20212802
May 2021705
Jun 2021001
Jul 2021104
Aug 2021101
Sep 2021106
Oct 202122018
Nov 202118010
Dec 2021600
Jan 2022704
Feb 20221803
Mar 20223804
Apr 2022801
May 20223808
Jun 20225508
Jul 20221600
Aug 20221801
Sep 20222409
Oct 20224803
Nov 20222403
Dec 20221103
Jan 20231304
Feb 2023502
Mar 2023501
Apr 2023101
May 20231402
Jun 2023201
Jul 2023804
Aug 2023602
Sep 2023401
Oct 2023904
Nov 20231202
Dec 20234003
Feb 2024401
Mar 202411012
Apr 20241506
May 2024408
Jun 2024801
Jul 2024002
Aug 2024504
Sep 20241802
Oct 20241005
Nov 20241303
Total10790235